KKR Of U.S. Said Bidding To Buy Third Of Gland Pharma For $30 Million
This article was originally published in PharmAsia News
Executive Summary
A U.S. investment company reportedly is set to acquire a major stake of another Asian pharmaceutical company, this time a third of Gland Pharma of India, for $10 million.